Skip to content

Dr Reddy#39;s drops 4% after being named in US anti-trust lawsuit

The complaint accuses Dr Reddy#39;s of improperly restraining competition and maintaining a monopoly in the sale of the cancer drug Revlimid

Read More

​ The complaint accuses Dr Reddy#39;s of improperly restraining competition and maintaining a monopoly in the sale of the cancer drug Revlimid The complaint accuses Dr Reddy#39;s of improperly restraining competition and maintaining a monopoly in the sale of the cancer drug Revlimid  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish